Guidance for market authorization requirements for COVID-19 vaccines: Overview
This document provides guidance to vaccine manufacturers seeking authorization for their vaccine that targets the SARS-CoV-2 virus. This guidance applies to applications under the interim order respecting the importation, sale and advertising of drugs for use in relation to COVID-19.
- Publisher
- Health Canada
- Resources
- 2
- Catalogue metadata updated
- 2022-07-28
Data overview
- Formats
- HTML
- File languages
- English, French